COVID-19: UK authorises anti-viral drug remdesivir

26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...

Read more →

NICE issues final guidance on NHS use of Bayer's Vitrakvi

27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...

Read more →

NICE recommends treatment for type of small-cell lung cancer

27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...

Read more →

NICE Chairman Sharmila Nebhrajani begins her new role

26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...

Read more →

Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE

22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...

Read more →

UK bulk buys hydroxychloroquine as potential COVID-19 treatment

20 May 2020 - Hydroxychloroquine is being bought in bulk by the UK in case it does turn out to ...

Read more →

NICE backs drug for lymphoma from Roche

13 May 2020 - NICE has recommended NHS funding for a cancer drug, giving final guidance on a new option ...

Read more →

NICE final guidance backs Pfizer's Lorviqua

13 May 2020 - NICE has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of ...

Read more →

Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies

7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy.  ...

Read more →

NICE draft guidance recommends new treatment option for people with early breast cancer

7 May 2020 - NICE has today published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) ...

Read more →

Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy

1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging.  ...

Read more →

AstraZeneca to make Oxford vaccine as COVID-19 race heats up

30 April 2020 - AstraZeneca agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race ...

Read more →

NICE joins international collaboratives to respond to the COVID-19 pandemic

30 April 2020 - NICE is supporting a growing number of international collaborations to share knowledge and identify treatments in response ...

Read more →

In race for a coronavirus vaccine, an Oxford group leaps ahead

27 April 2020 - As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to ...

Read more →

NICE U-turn backs Stelara for ulcerative colitis

28 April 2020 - NICE has now issued a positive Final Appraisal Document recommending Janssen's Stelara (ustekinumab) as an option ...

Read more →